Agonoxincdevelops Novel Therapies To Treat Cancer Patientsthe Research Strategy At Agonox Focuses On The Interaction Between T Cells And Tumor Cells Using Bioinformaticsin Vitroand In Vivo Testing To Identify And Validate New Therapeutic Approaches Agonox Conducts Its Research In Laboratories At The Portland Providence Cancer Center Where Staff Scientists Work Closely With Oncologistssurgeonsand Immunologists This Collaboration Has Led To Two First In Human Clinical Trials With The Latest Commencing In August 2023The Company S Focus In Recent Years Has Been Utilizing Selected Tumor Reactive T Cells In Adoptive Cell Therapy For The Treatment Of Patients With Solid Malignancies
Bio International Convention 2025
United States
16 Jun 2025
2765
| Company Name | Agonox Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
